InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 05/07/2019 4:10:35 PM

Tuesday, May 07, 2019 4:10:35 PM

Post# of 2808
News: $BLRX BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors

TEL AVIV, Israel , May 7, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application...

Find out more https://marketwirenews.com/news-releases/biolinerx-announces-fda-approval-of-ind-application-for-agi-134-a-novel-immunotherapy-anti-cancer-vaccine-for-solid-tumors-8130838.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News